Home > Boards > US OTC > Cannabis > Can B Corp. (CANB)

To Canbiola Management:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
simps Member Profile
 
Followed By 1
Posts 25
Boards Moderated 0
Alias Born 08/20/15
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/23/2021 7:05:02 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 3:46:44 PM
Can B Corp. Accelerates its Innovations and Advancements at Pure Health Products InvestorsHub NewsWire - 2/16/2021 8:27:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2021 3:17:46 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/30/2020 12:19:28 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 3:22:51 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/15/2020 6:29:48 AM
Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering... Edgar (US Regulatory) - 9/25/2020 6:02:27 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/22/2020 2:23:51 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 9/4/2020 3:43:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2020 9:41:26 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2020 4:43:34 PM
Notice of Qualification [regulation A] (qualif) Edgar (US Regulatory) - 8/10/2020 6:36:05 AM
Big Data Analytics Delivers During the Pandemic NetworkNewsWire - 6/30/2020 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2020 9:03:01 AM
Registration a Offering Under the Securities Act of 1933 (1-a) Edgar (US Regulatory) - 6/3/2020 6:02:08 AM
Can B Corp Announces First Quarter 2020 Results Increased Quarterly Revenue, Outpacing Expense InvestorsHub NewsWire - 5/26/2020 7:29:34 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2020 4:24:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/19/2020 6:04:12 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/14/2020 5:15:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/10/2020 1:07:33 PM
Can B Corp Update Regarding Stock Restructure InvestorsHub NewsWire - 3/6/2020 12:52:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/3/2020 4:47:53 PM
simps   Wednesday, 09/11/19 01:41:48 AM
Re: None
Post # of 27334 
To Canbiola Management:
I’ve been holding this stock for a very long time and even accumulated lately but while I see many positives, I feel there’s a need for the company to focus and also bring clarity to some of the PR’s and statements made during the shareholders meeting.
I find it very positive that Revenues are growing tremendously for such a small company and am impressed of money raised in the last two private placements, the latest being about $4M at $0.029.
For clarity maybe you can shed some light in a stockholder memo or other public fashion about a few items:
1. SAM’s units – how many have you purchased and what is the adoption rate and usage utilization on a monthly basis? If you have not kept buying additional units per the company’s commitment announced, then why not?
2. Vending machines, what is the strategy? What is the investment of the ordered machines? What is expected revenues? If to place them in doctors’ offices, then I question why visitors wouldn’t just buy the products from the staff instead.
3. Northwell Hospital, is there an agreement with them or are they considered a regular customer? Where in the hospital are the products sold and which products? Does the hospital also sell competing CBD products or does Canbiola have an exclusive?
4. BOD member, advisors et all: What do they bring to the table in return for stock?
5. Expenses and Profit: Even though revenue has exploded so has expenses, will this continue, or do you see a path to profitability/positive cash flow? If so, when?
6. Seed to Oil: what is the strategy for controlling the entire process? Do you envision buying land and starting from scratch or is the goal to purchase/lease parts/all of existing facilities with production capabilities? How about building relationships with growers who can supply raw material?
7. Lab reports: Will these be updated to more current dates?
8. Any plans for product expansion within CBD and beyond (adding THC for example)?
9. Pure Leaf: Any plans of taking this onto Amazon and similar platforms?
10. Nasdaq: what is the strategy of meeting the requirements, especially min stock price and asset and/or revenue requirements? Expected timeline?
11. Investors relations firm: what are they doing to firm up the base and bring new investors?
12. Anything else that you think will benefit shareholders?
I have not sold and continue holding but getting a clearer picture would benefit my self and surely others.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences